This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Research Revealed On World Hepatitis Day Shows Countries Ill-equipped To Cope With Silent Epidemic

LONDON, July 28, 2013 /PRNewswire/ --

World Hepatitis Alliance calls for urgent action to address disease killing as many as HIV/AIDS

 

On World Hepatitis Day, the World Hepatitis Alliance has called for urgent attention to be given to recent figures showing that although viral hepatitis kills as many as HIV/AIDS, the great majority of countries have no programmes in place to tackle it.

     (Logo: http://photos.prnewswire.com/prnh/20130728/630031-a )

     (Logo: http://photos.prnewswire.com/prnh/20130728/630031-b )

     (Photo: http://photos.prnewswire.com/prnh/20130728/630031-c )

     (Photo: http://photos.prnewswire.com/prnh/20130728/630031-d ) The Global Burden of Disease study released last year in the Lancet shows that viral hepatitis was responsible for almost 1.45 million deaths in 2010, the same as HIV/AIDS and significantly more than TB or Malaria. Despite this enormous annual death toll, leaders in global health consistently leave it off their agendas.

'Viral hepatitis is the 8th leading cause of death worldwide, killing as many people as HIV/AIDS every single year' says Charles Gore, President of the World Hepatitis Alliance. '500 million people worldwide are chronically infected. In the face of these numbers how is it possible that viral hepatitis receives so little priority across the world?'

Currently, diseases receive attention and funding depending on their global priority. However the global priority list does not necessarily reflect the real burden of disease. This has led to responses that are disproportionate to disease impact, and has left some diseases tragically under-resourced. Viral hepatitis is a clear example; despite its huge burden there is little global pressure to address it. Consequently, the majority of governments have failed to dedicate resources to viral hepatitis, even in countries where prevalence is up to 20%.

The Global Report released by the World Health Organization last week showed the extent to which viral hepatitis is ignored. Only 37% of countries have a national strategy or plan for viral hepatitis, and less than 30% reported having a department responsible solely for viral hepatitis related activities. The lack of response to the world's 8 th biggest killer is truly baffling. Not only does it put millions of lives at risk by allowing this silent epidemic to grow, it leaves the 500 million people who are chronically infected wholly abandoned without support or recognition.

In 2010 the World Health Organisation openly recognised that viral hepatitis is a major cause for concern by making World Hepatitis Day one of only 7 world health days officially recognised by WHO and all Member States. However, major changes to the global health landscape are yet to be seen. This World Hepatitis Day, the World Hepatitis Alliance has therefore launched a mass awareness campaign under the theme 'This is hepatitis. Know it. Confront it.' to encourage people to find out more and to confront the silence around the disease.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,960.57 -123.23 -0.72%
S&P 500 1,978.34 -9.64 -0.48%
NASDAQ 4,449.5640 -22.5440 -0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs